BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24463170)

  • 1. Identification of motives mediating alternative functions of the neomorphic moonlighting TPPP/p25.
    Tőkési N; Oláh J; Hlavanda E; Szunyogh S; Szabó A; Babos F; Magyar A; Lehotzky A; Vass E; Ovádi J
    Biochim Biophys Acta; 2014 Apr; 1842(4):547-57. PubMed ID: 24463170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual life of TPPP/p25 evolved in physiological and pathological conditions.
    Oláh J; Ovádi J
    Biochem Soc Trans; 2014 Dec; 42(6):1762-7. PubMed ID: 25399603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenging drug target for Parkinson's disease: Pathological complex of the chameleon TPPP/p25 and alpha-synuclein proteins.
    Szénási T; Oláh J; Szabó A; Szunyogh S; Láng A; Perczel A; Lehotzky A; Uversky VN; Ovádi J
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):310-323. PubMed ID: 27671864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the interface of the pathological complex of α-synuclein and TPPP/p25.
    Szunyogh S; Oláh J; Szénási T; Szabó A; Ovádi J
    Biochim Biophys Acta; 2015 Dec; 1852(12):2653-61. PubMed ID: 26407520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein.
    Oláh J; Vincze O; Virók D; Simon D; Bozsó Z; Tõkési N; Horváth I; Hlavanda E; Kovács J; Magyar A; Szũcs M; Orosz F; Penke B; Ovádi J
    J Biol Chem; 2011 Sep; 286(39):34088-100. PubMed ID: 21832049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc-induced structural changes of the disordered tppp/p25 inhibits its degradation by the proteasome.
    Lehotzky A; Oláh J; Szunyogh S; Szabó A; Berki T; Ovádi J
    Biochim Biophys Acta; 2015 Jan; 1852(1):83-91. PubMed ID: 25445539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TPPP/p25 promotes tubulin acetylation by inhibiting histone deacetylase 6.
    Tokési N; Lehotzky A; Horváth I; Szabó B; Oláh J; Lau P; Ovádi J
    J Biol Chem; 2010 Jun; 285(23):17896-906. PubMed ID: 20308065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zn²+-induced rearrangement of the disordered TPPP/p25 affects its microtubule assembly and GTPase activity.
    Zotter Á; Oláh J; Hlavanda E; Bodor A; Perczel A; Szigeti K; Fidy J; Ovádi J
    Biochemistry; 2011 Nov; 50(44):9568-78. PubMed ID: 21995432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological targeting of α-synuclein and TPPP/p25 in Parkinson's disease: challenges and opportunities in a Nutshell.
    Oláh J; Ovádi J
    FEBS Lett; 2019 Jul; 593(13):1641-1653. PubMed ID: 31148150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moonlighting microtubule-associated proteins: regulatory functions by day and pathological functions at night.
    Oláh J; Tőkési N; Lehotzky A; Orosz F; Ovádi J
    Cytoskeleton (Hoboken); 2013 Nov; 70(11):677-85. PubMed ID: 24039085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the microtubule-associated TPPP/p25 in Parkinson's and related diseases and its therapeutic potential.
    Oláh J; Bertrand P; Ovádi J
    Expert Rev Proteomics; 2017 Apr; 14(4):301-309. PubMed ID: 28271739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Aggregative Effect of the Antioxidant DJ-1 on the TPPP/p25-Derived Pathological Associations of Alpha-Synuclein.
    Oláh J; Lehotzky A; Szénási T; Ovádi J
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microtubule-Associated Proteins with Regulatory Functions by Day and Pathological Potency at Night.
    Oláh J; Lehotzky A; Szunyogh S; Szénási T; Orosz F; Ovádi J
    Cells; 2020 Feb; 9(2):. PubMed ID: 32033023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubulin polymerization promoting proteins (TPPPs): members of a new family with distinct structures and functions.
    Vincze O; Tökési N; Oláh J; Hlavanda E; Zotter A; Horváth I; Lehotzky A; Tirián L; Medzihradszky KF; Kovács J; Orosz F; Ovádi J
    Biochemistry; 2006 Nov; 45(46):13818-26. PubMed ID: 17105200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TPPP/p25: from unfolded protein to misfolding disease: prediction and experiments.
    Orosz F; Kovács GG; Lehotzky A; Oláh J; Vincze O; Ovádi J
    Biol Cell; 2004 Dec; 96(9):701-11. PubMed ID: 15567525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies.
    Kovács GG; László L; Kovács J; Jensen PH; Lindersson E; Botond G; Molnár T; Perczel A; Hudecz F; Mezo G; Erdei A; Tirián L; Lehotzky A; Gelpi E; Budka H; Ovádi J
    Neurobiol Dis; 2004 Nov; 17(2):155-62. PubMed ID: 15474353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further evidence for microtubule-independent dimerization of TPPP/p25.
    Oláh J; Szénási T; Szunyogh S; Szabó A; Lehotzky A; Ovádi J
    Sci Rep; 2017 Jan; 7():40594. PubMed ID: 28074911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self protein-protein interactions are involved in TPPP/p25 mediated microtubule bundling.
    DeBonis S; Neumann E; Skoufias DA
    Sci Rep; 2015 Aug; 5():13242. PubMed ID: 26289831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation Of Microtubule Acetylation By The Interplay Of TPPP/p25, SIRT2 And New Anticancer Agents With Anti-SIRT2 Potency.
    Szabó A; Oláh J; Szunyogh S; Lehotzky A; Szénási T; Csaplár M; Schiedel M; Lőw P; Jung M; Ovádi J
    Sci Rep; 2017 Dec; 7(1):17070. PubMed ID: 29213065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The brain-specific protein TPPP/p25 in pathological protein deposits of neurodegenerative diseases.
    Kovács GG; Gelpi E; Lehotzky A; Höftberger R; Erdei A; Budka H; Ovádi J
    Acta Neuropathol; 2007 Feb; 113(2):153-61. PubMed ID: 17123092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.